company background image
0J8Z

Illumina LSE:0J8Z Stock Report

Last Price

US$199.40

Market Cap

US$32.2b

7D

1.6%

1Y

-46.6%

Updated

22 Jan, 2023

Data

Company Financials +

0J8Z Stock Overview

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis.

0J8Z fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 13.2% below our estimate of its fair value

Earnings are forecast to grow 62.83% per year

Risk Analysis

No risks detected for 0J8Z from our risk checks.

My Notes

New

Notes are coming soon

Illumina, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Illumina
Historical stock prices
Current Share PriceUS$199.40
52 Week HighUS$369.46
52 Week LowUS$173.30
Beta1.13
1 Month Change3.16%
3 Month Change-8.95%
1 Year Change-46.57%
3 Year Change-40.43%
5 Year Changen/a
Change since IPO-18.56%

Recent News & Updates

Recent updates

Shareholder Returns

0J8ZGB Life SciencesGB Market
7D1.6%-9.4%-1.0%
1Y-46.6%-43.9%-5.8%

Return vs Industry: 0J8Z underperformed the UK Life Sciences industry which returned -43.9% over the past year.

Return vs Market: 0J8Z underperformed the UK Market which returned -5.8% over the past year.

Price Volatility

Is 0J8Z's price volatile compared to industry and market?
0J8Z volatility
0J8Z Average Weekly Movement6.8%
Life Sciences Industry Average Movement6.5%
Market Average Movement5.2%
10% most volatile stocks in GB Market10.9%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0J8Z is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 0J8Z's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19989,825Francis deSouzahttps://www.illumina.com

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services.

Illumina, Inc. Fundamentals Summary

How do Illumina's earnings and revenue compare to its market cap?
0J8Z fundamental statistics
Market CapUS$32.15b
Earnings (TTM)-US$4.15b
Revenue (TTM)US$4.70b

6.8x

P/S Ratio

-7.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
0J8Z income statement (TTM)
RevenueUS$4.70b
Cost of RevenueUS$1.42b
Gross ProfitUS$3.28b
Other ExpensesUS$7.44b
Earnings-US$4.15b

Last Reported Earnings

Oct 02, 2022

Next Earnings Date

Feb 07, 2023

Earnings per share (EPS)-26.40
Gross Margin69.83%
Net Profit Margin-88.36%
Debt/Equity Ratio25.9%

How did 0J8Z perform over the long term?

See historical performance and comparison